{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:17:01Z","timestamp":1741839421949,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,12]]},"DOI":"10.7759\/cureus.80459","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:36:01Z","timestamp":1741779361000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Lupus Nephritis and Renal Clear-Cell Carcinoma: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Tha\u00eds Fontenele","family":"da Ponte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysiane Maria Adeodato Ramos","family":"Fontenelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Carlos","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuelle de Matos","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman A","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008, 358:929-39. 10.1056\/NEJMra071297","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860794","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies","volume":"12","author":"Zhang M","year":"2022","unstructured":"Zhang M, Wang Y, Wang Y, Bai Y, Gu D. Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies. Front Oncol. 2022, 12:860794. 10.3389\/fonc.2022.860794","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.013","article-title":"A review on SLE and malignancy","volume":"31","author":"Choi MY","year":"2017","unstructured":"Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017, 31:373-96. 10.1016\/j.berh.2017.09.013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1384054","article-title":"Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up","volume":"47","author":"Tallbacka KR","year":"2018","unstructured":"Tallbacka KR, Pettersson T, Pukkala E. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up. Scand J Rheumatol. 2018, 47:461-4. 10.1080\/03009742.2017.1384054","journal-title":"Scand J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh JJ","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, et al.. Renal cell carcinoma. Nat Rev Dis Primers. 2017, 3:17009. 10.1038\/nrdp.2017.9","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta J","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009, 70:39-58. 10.1016\/j.critrevonc.2008.08.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th Edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem AA","year":"2021","unstructured":"Elkassem AA, Allen BC, Sharbidre KG, Rais-Bahrami S, Smith AD. Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th Edition, from the AJR special series on cancer staging. AJR Am J Roentgenol. 2021, 217:541-55. 10.2214\/AJR.21.25493","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318804883","article-title":"Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea","volume":"27","author":"Lim SY","year":"2018","unstructured":"Lim SY, Bae EH, Han KD, et al.. Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea. Lupus. 2018, 27:2050-6. 10.1177\/0961203318804883","journal-title":"Lupus"},{"key":"ref10","article-title":"Renal cell carcinoma with proliferative lupus nephritis","volume":"2015","author":"Wong KW","year":"2015","unstructured":"Wong KW. Renal cell carcinoma with proliferative lupus nephritis. BMJ Case Rep. 2015, 2015:bcr2014208060.","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31870","article-title":"Lupus nephritis associated with renal cell carcinoma","volume":"14","author":"Mehta V","year":"2022","unstructured":"Mehta V, Gandhi D. Lupus nephritis associated with renal cell carcinoma. Cureus. 2022, 14:e31870. 10.7759\/cureus.31870","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11434\/kyorinmed.41.38","article-title":"A case of lupus nephritis complicated with renal cell carcinoma","volume":"41","author":"Matsuda T","year":"2010","unstructured":"Matsuda T, Karube M, Hayakawa T, Arimura Y, Yamada A, Nutahara K. A case of lupus nephritis complicated with renal cell carcinoma. J Kyorin Med Soc. 2010, 41:38-43. 10.11434\/kyorinmed.41.38","journal-title":"J Kyorin Med Soc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000157399","article-title":"Renal cell carcinoma in a patient with systemic lupus erythematosus: a case report","volume":"5","author":"Gopalakrishnan G","year":"1996","unstructured":"Gopalakrishnan G, Nampoory NM, Ali JH, Johny KV. Renal cell carcinoma in a patient with systemic lupus erythematosus: a case report. Med Princ Pract. 1996, 5:160-2. 10.1159\/000157399","journal-title":"Med Princ Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli A","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014, 13:272-80. 10.1016\/j.autrev.2013.10.010","journal-title":"Autoimmun Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-002-0807-2","article-title":"CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region","volume":"111","author":"Hudson LL","year":"2002","unstructured":"Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet. 2002, 111:452-5. 10.1007\/s00439-002-0807-2","journal-title":"Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh331","article-title":"Factors associated with abnormal Pap results in systemic lupus erythematosus","volume":"43","author":"Bernatsky S","year":"2004","unstructured":"Bernatsky S, Ramsey-Goldman R, Gordon C, et al.. Factors associated with abnormal Pap results in systemic lupus erythematosus. Rheumatology (Oxford). 2004, 43:1386-9. 10.1093\/rheumatology\/keh331","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson R","year":"2005","unstructured":"Robson R, Cecka JM, Opelz G, Budde M, Sacks S. Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant. 2005, 5:2954-60. 10.1111\/j.1600-6143.2005.01125.x","journal-title":"Am J Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams C","year":"1996","unstructured":"Talar-Williams C, Hijazi YM, Walther MM, et al.. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996, 124:477-84. 10.7326\/0003-4819-124-5-199603010-00003","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224024","article-title":"Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy","volume":"14","author":"Ryu J","year":"2019","unstructured":"Ryu J, Ryu H, Kim S, Chin HJ, Na KY, Chae DW, Yoon HJ. Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy. PLoS One. 2019, 14:e0224024. 10.1371\/journal.pone.0224024","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Escudier B","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, et al.. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019, 30:706-20. 10.1093\/annonc\/mdz056","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347330-association-between-lupus-nephritis-and-renal-clear-cell-carcinoma-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:36:03Z","timestamp":1741779363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347330-association-between-lupus-nephritis-and-renal-clear-cell-carcinoma-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.80459","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}